{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:07:10Z","timestamp":1793304430660,"version":"4.5.0"},"reference-count":62,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: In the broad and current context of antimicrobial resistance, antibiotic management and therapeutic surveillance are essential in hospitals. The present study (five-year retrospective, 2020\u20132024) aimed to analyze antibiotic consumption in relation to pathogens identified in a multidisciplinary hospital. Results: In terms of antibiotic consumption (overall 2020\u20132024), although initially Watch antibiotics were predominantly used, a decrease was observed in favor of Access class antibiotics (sharply increase from 2022 to 2023 and maximum in 2024). For Reserve antibiotics, only slight annual fluctuations were observed, but there was an important reduction in colistin consumption. The most used were cephalosporins (cefazolin, cefuroxime and ceftriaxone), carbapenems (meropenem and ertapenem), vancomycin and linezolid. Regarding pathogens, the most notable were: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Enterococcus spp., Pseudomonas aeruginosa. Among the ESKAPE bacteria, Acinetobacter baumannii was the least frequent in our samples. ESKAPE bacteria predominantly colonized specimens from the respiratory tract, digestive tract, skin and soft tissue. Resistant strains were observed, mainly Methicillin-resistant Staphylococcus aureus (MRSA) and Extended-Spectrum Beta-Lactamase (ESBL) Klebsiella spp., but no alarming increases in number were recorded in the analyzed period. Methods: The analysis was carried out using tools recommended by the World Health Organisation (Access Watch Reserve antibiotics classification (AWaRe); Bacterial Priority Pathogen List (BBPL); Defined Daily Dose (DDD)), Average Annual Percent Change (AAPC) calculation and ESKAPE classification (bacteria group: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.). Conclusions: Relatively stable trends in bacterial isolates and resistant strains over five years (2020\u20132024) are consistent with effective antimicrobial stewardship practices.<\/jats:p>","DOI":"10.3390\/antibiotics15030288","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:23:03Z","timestamp":1773307383000},"page":"288","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of Antibiotic Consumption Trends and Pathogens\u2019 Epidemiological Profile Within a Multidisciplinary Clinical Hospital from Romania"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1228-9425","authenticated-orcid":false,"given":"Andreea-Roxana","family":"Ungureanu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Sanador Clinical Hospital, 010991 Bucharest, Romania"},{"name":"Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, \u201cCarol Davila\u201d Univesity of Medicine and Pharmacy, 020945 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea-Alina","family":"Dumitru","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Hospital Laboratory, Sanador Clinical Hospital, 010991 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma-Adriana","family":"Ozon","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, \u201cCarol Davila\u201d Univesity of Medicine and Pharmacy, 020945 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei-Tudor","family":"Rogoz","sequence":"additional","affiliation":[{"name":"Department of Healthcare-Associated Infections, Sanador Clinical Hospital, 010991 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca-Narcisa","family":"Anghel","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sanador Clinical Hospital, 010991 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ciucu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sanador Clinical Hospital, 010991 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4705-4204","authenticated-orcid":false,"given":"Ancu\u021ba-C\u0103t\u0103lina","family":"Fi\u021ba","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, \u201cCarol Davila\u201d Univesity of Medicine and Pharmacy, 020945 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9882-5876","authenticated-orcid":false,"given":"Nicoleta-Mirela","family":"Blebea","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, Faculty of Pharmacy, Ovidius University of Constan\u021ba, 900001 Constan\u021ba, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Salam, M.A., Al-Amin, M.Y., Salam, M.T., Pawar, J.S., Akhter, N., Rabaan, A.A., and Alqumber, M.A.A. (2023). Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare, 11.","DOI":"10.20944\/preprints202305.0555.v1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13643-024-02731-w","article-title":"The impact of antimicrobial stewardship interventions on appropriate use of surgical antimicrobial prophylaxis in low- and middle-income countries: A systematic review","volume":"13","author":"Sefah","year":"2024","journal-title":"Syst. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s10096-025-05126-4","article-title":"Emerging antibiotic resistance by various novel proteins\/enzymes","volume":"44","author":"Sun","year":"2025","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"102490","DOI":"10.1016\/j.jiph.2024.102490","article-title":"In-hospital use of antibiotics in internal medicine: A cross-sectional study before, during and after the COVID-19 pandemic in a COVID-19-free ward","volume":"17","author":"Bellanti","year":"2024","journal-title":"J. Infect. Public Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"ofaf045","DOI":"10.1093\/ofid\/ofaf045","article-title":"National Trends in Antibiotic Prescribing for Adults Hospitalized With Coronavirus Disease 2019 and Other Viral Respiratory Infections","volume":"12","author":"Pulia","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sulayyim, H.J.A., Ismail, R., Hamid, A.A., and Ghafar, N.A. (2022). Antibiotic Resistance during COVID-19: A Systematic Review. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph191911931"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"De La Motte, L.R., Deflorio, L., Stefano, E., Covi, M., Uslenghi, A., Sommese, C., and Drago, L. (2025). Evolution of Respiratory Pathogens and Antimicrobial Resistance over the COVID-19 Timeline: A Study of Hospitalized and Ambulatory Patient Populations. Antibiotics, 14.","DOI":"10.3390\/antibiotics14080796"},{"key":"ref_9","unstructured":"World Health Organization (2024). WHO Reports Widespread Overuse of Antibiotics in Patients Hospitalized with COVID-19. Neurosciences, 29, 213\u2013214."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2471\/BLT.22.288614","article-title":"The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance","volume":"101","author":"Zanichelli","year":"2023","journal-title":"Bull. World Health Organ."},{"key":"ref_11","unstructured":"World Health Organization (2024). WHO Bacterial Priority Pathogens List 2024: Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance, World Health Organization. [1st ed.]. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240093461."},{"key":"ref_12","unstructured":"World Health Organization (2022). The WHO AWaRe (Access, Watch, Reserve) Antibiotic Book, World Health Organization. [1st ed.]. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240062382."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Almomani, B.A., Hijazi, B.M., Awwad, O., and Khasawneh, R.A. (2022). Prevalence and predictors of non-adherence to short-term antibiotics: A population-based survey. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0268285"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Haag, M., Hersberger, K.E., and Arnet, I. (2021). Assessing Medication Adherence Barriers to Short-Term Oral Antibiotic Treatment in Primary Care\u2014Development and Validation of a Self-Report Questionnaire (BIOTICA). Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18157768"},{"key":"ref_15","first-page":"178","article-title":"Antimicrobial resistance pattern in healthcare-associated infections: Investigation of in-hospital risk factors","volume":"13","author":"Foroushani","year":"2021","journal-title":"Iran. J. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sartelli, M., Marini, C.P., McNelis, J., Coccolini, F., Rizzo, C., Labricciosa, F.M., and Petrone, P. (2024). Preventing and Controlling Healthcare-Associated Infections: The First Principle of Every Antimicrobial Stewardship Program in Hospital Settings. Antibiotics, 13.","DOI":"10.3390\/antibiotics13090896"},{"key":"ref_17","first-page":"14","article-title":"Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections","volume":"3","author":"Mustafa","year":"2024","journal-title":"Barw Med. J."},{"key":"ref_18","first-page":"407","article-title":"Antibiotherapy in hospital\u2014Between the efficiency and quality of medical services. The role of the drug committee","volume":"63","author":"Daina","year":"2015","journal-title":"Farmacia"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mazzitelli, M., Mengato, D., Barbato, G., Lo Menzo, S., Dalla Valle, F., Boschetto, M., Stano, P., Contessa, C., Don\u00e0, D., and Scaglione, V. (2025). Outcomes of Implementing a Multidimensional Antimicrobial Stewardship Program in a Medical Ward in a Third-Level University Hospital in Northern Italy. Antibiotics, 14.","DOI":"10.3390\/antibiotics14070683"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e45778","DOI":"10.1097\/MD.0000000000045778","article-title":"Adverse events associated with third-generation cephalosporins: Analysis of the FDA adverse event reporting system database","volume":"104","author":"Ahmed","year":"2025","journal-title":"Medicine"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Carcamo, P., Walter, E., Frei, C.R., Yang, L., Cadena, J., and Hopkins, T. (2025). A comparison of empiric therapy with cefazolin versus ceftriaxone for patients with complicated urinary tract infections in a tertiary care veterans affairs medical center. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-10494-5"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clinthera.2024.02.011","article-title":"Comparison of Cefazolin and Ceftriaxone Enterobacterales Susceptibilities for Inpatient Treatment of Urinary Tract Infections and Risk of Hospital-onset Clostridioides difficile Infection","volume":"46","author":"Wombwell","year":"2024","journal-title":"Clin. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13741-025-00635-4","article-title":"Optimizing perioperative antibiotic prophylaxis: A prospective cohort study on cefazolin utilization in surgical patients with penicillin allergy labels","volume":"15","author":"Mensah","year":"2025","journal-title":"Perioper. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cmi.2019.03.010","article-title":"Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia","volume":"25","author":"Weis","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Prosty, C., Noutsios, D., Lee, T.C., Daneman, N., Davis, J.S., Jager, N.G.L., Ghanem-Zoubi, N., Goodman, A.L., Kaasch, A.J., and Kouijzer, I. (2025). Cefazolin versus Antistaphylococcal Penicillins for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis. medRxiv.","DOI":"10.1101\/2025.02.17.25322429"},{"key":"ref_26","unstructured":"World Health Organization (2025, December 28). Global Antimicrobial Resistance and Use Surveillance System (GLASS). Available online: https:\/\/worldhealthorg.shinyapps.io\/glass-dashboard\/_w_b7954b7a6c0d4ae592139f1bff6d904d\/#!\/home."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wang, Y., Li, Y., Gao, M., Zhang, M., Li, Y., Wang, D., Li, X., Zhang, C., Fu, Y., and Li, H. (2025). Continuous vs. intermittent meropenem infusion in critically ill patients with sepsis: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1580116"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Malviya, M., Kale-Pradhan, P., Coyle, M., Giuliano, C., and Johnson, L.B. (2024). Clinical and Drug Resistance Characteristics of Providencia Infections. Microorganisms, 12.","DOI":"10.3390\/microorganisms12102085"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/jrms.JRMS_634_18","article-title":"Prevalence and antibiotic resistance pattern of extended-spectrum beta-lactamase-producing Escherichia coli in clinical specimens","volume":"24","author":"Shirani","year":"2019","journal-title":"J. Res. Med. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3855\/jidc.10827","article-title":"Antibiotic consumption and healthcare-associated infections in a tertiary hospital in Belgrade, Serbia from 2011 to 2016","volume":"12","year":"2018","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_31","first-page":"90","article-title":"Carbapenem resistant strains of Pseudomonas aeruginosa among patients in Minia university hospitals","volume":"36","author":"Ali","year":"2024","journal-title":"Minia J. Med. Res."},{"key":"ref_32","first-page":"693","article-title":"Detection of carbapenem-resistant Pseudomonas aeruginosa in tertiary care hospital in Saudi Arabia","volume":"3","author":"Khater","year":"2022","journal-title":"Microbes Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Piotrowski, M., Alekseeva, I., Arnet, U., and Y\u00fccel, E. (2024). Insights into the Rising Threat of Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa Epidemic Infections in Eastern Europe: A Systematic Literature Review. Antibiotics, 13.","DOI":"10.3390\/antibiotics13100978"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Adeyemi, F.M., Akinlade, E.A., Yusuf-Omoloye, N.A., Ajigbewu, O.H., Dare, A.P., Wahab, A.A., Oyedara, O.O., Isiaka, H.S., and Usamat, A.O. (2025). Carbapenem-resistance in Acinetobacter baumannii: Prevalence, antibiotic resistance profile and carbapenemase genes in clinical and hospital environmental strains. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-11169-x"},{"key":"ref_35","first-page":"e31486","article-title":"An Update on Treatment Options for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: A Systematic Review","volume":"14","author":"Mahjabeen","year":"2022","journal-title":"Cureus"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/jac\/dky075","article-title":"Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: A nested case-control study","volume":"73","author":"Gouliouris","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13756-024-01498-y","article-title":"Oral vancomycin use and incidence of vancomycin-resistant enterococci: Time-series analysis","volume":"13","author":"Bae","year":"2024","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2001628","DOI":"10.2807\/1560-7917.ES.2021.26.45.2001628","article-title":"Hospital-acquired infections caused by enterococci: A systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020","volume":"26","author":"Brinkwirth","year":"2021","journal-title":"Eurosurveillance"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4315030","DOI":"10.1155\/2022\/4315030","article-title":"Colistin Resistance and Management of Drug Resistant Infections","volume":"2022","author":"Sharma","year":"2022","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12941-025-00799-3","article-title":"Prevalence, trends, and molecular insights into colistin resistance among gram-negative bacteria in Egypt: A systematic review and meta-analysis","volume":"24","author":"Azzam","year":"2025","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/ejhpharm-2020-002606","article-title":"Quantifying the effect of in-hospital antimicrobial use on the development of colistin-resistant Acinetobacter baumannii strains: A time series analysis","volume":"29","author":"Kousovista","year":"2022","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Szab\u00f3, S., Feier, B., Capatina, D., Tertis, M., Cristea, C., and Popa, A. (2022). An Overview of Healthcare Associated Infections and Their Detection Methods Caused by Pathogen Bacteria in Romania and Europe. J. Clin. Med., 11.","DOI":"10.3390\/jcm11113204"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"39053","DOI":"10.1038\/s41598-025-26212-9","article-title":"Correlation of broad-spectrum antibiotic utilization patterns with invasive candidiasis in critically ill patients and development of an early prediction model","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/cid\/ciae259","article-title":"Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection","volume":"79","author":"Ray","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Pipit\u00f2, L., Rubino, R., D\u2019Agati, G., Bono, E., Mazzola, C.V., Urso, S., Zinna, G., Distefano, S.A., Firenze, A., and Bonura, C. (2025). Antimicrobial Resistance in ESKAPE Pathogens: A Retrospective Epidemiological Study at the University Hospital of Palermo, Italy. Antibiotics, 14.","DOI":"10.3390\/antibiotics14020186"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Pipit\u00f2, L., Bono, E., Mazzola, C.V., Rubino, R., Anastasia, A., Distefano, S.A., Firenze, A., Giammanco, G.M., Bonura, C., and Cascio, A. (2025). Outcome of Bloodstream Infections Caused by Antibiotic-Resistant Bacteria: A 7-Year Retrospective Study at the University Hospital of Palermo, Italy. Antibiotics, 14.","DOI":"10.3390\/antibiotics14050464"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Giamarellou, H., Galani, L., Karavasilis, T., Ioannidis, K., and Karaiskos, I. (2023). Antimicrobial Stewardship in the Hospital Setting: A Narrative Review. Antibiotics, 12.","DOI":"10.3390\/antibiotics12101557"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e2253806","DOI":"10.1001\/jamanetworkopen.2022.53806","article-title":"Association Between Antimicrobial Stewardship Programs and Antibiotic Use Globally: A Systematic Review and Meta-Analysis","volume":"6","author":"Win","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2471\/BLT.20.270934","article-title":"Progress towards antibiotic use targets in eight high-income countries","volume":"99","author":"Simmons","year":"2021","journal-title":"Bull. World Health Organ."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"dlaf031","DOI":"10.1093\/jacamr\/dlaf031","article-title":"Increasing the use of the WHO AWaRe system in antibiotic surveillance and stewardship programmes in low- and middle-income countries","volume":"7","author":"Saleem","year":"2025","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Tamma, P.D., Heil, E.L., Justo, J.A., Mathers, A.J., Satlin, M.J., and Bonomo, R.A. (2024). Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin. Infect. Dis., ciae403.","DOI":"10.1093\/cid\/ciae403"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines","volume":"86","author":"Kranz","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_54","unstructured":"(2025, December 12). WHO Collaborating Centre for Drug Statistics Methodology, DDD Index, 2025. Available online: https:\/\/atcddd.fhi.no\/atc_ddd_index\/."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Hollingworth, S., and Kairuz, T. (2021). Measuring Medicine Use: Applying ATC\/DDD Methodology to Real-World Data. Pharmacy, 9.","DOI":"10.3390\/pharmacy9010060"},{"key":"ref_56","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2024). Guidelines for ATC Classification and DDD Assignment 2025, WHO Collaborating Centre for Drug Statistics Methodology. Available online: https:\/\/atcddd.fhi.no\/atc_ddd_index_and_guidelines\/guidelines\/."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1002\/sim.7344","article-title":"Improved confidence interval for average annual percent change in trend analysis","volume":"36","author":"Kim","year":"2017","journal-title":"Stat. Med."},{"key":"ref_58","unstructured":"(2025, December 15). Joinpoint Trend Analysis Software, Available online: https:\/\/surveillance.cancer.gov\/joinpoint\/."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Akhmetova, K., Makalkina, L., Pivina, L., Lim, L., Aukenov, N., Boranbayev, K., Stukas, R., Belikhina, T., Aldiyarova, N., and Turgambayeva, A. (2025). Trends in \u2018Watch\u2019 and \u2018Reserve\u2019 Antibiotic Use in Primary Care in Kazakhstan: The Imperative for Enhancing Stewardship Strategies. Antibiotics, 14.","DOI":"10.3390\/antibiotics14100963"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12966-020-01029-z","article-title":"Zero problems with compositional data of physical behaviors: A comparison of three zero replacement methods","volume":"17","author":"Rasmussen","year":"2020","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jhin.2025.06.006","article-title":"The burden of ESKAPE pathogen-related hospital-acquired infections: Clinical and financial perspective from a systematic review","volume":"162","author":"Woh","year":"2025","journal-title":"J. Hosp. Infect."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"114006","DOI":"10.1016\/j.ijheh.2022.114006","article-title":"Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community-acquired infection and risk to human health","volume":"244","author":"Denissen","year":"2022","journal-title":"Int. J. Hyg. Environ. Health"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/3\/288\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:20:14Z","timestamp":1773310814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/3\/288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["antibiotics15030288"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15030288","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}